1. Goto D, Yagi K, Inoue H, Iwamoto I, Kawabata M, Miyazono K, Kato M. A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negativeeffect on TGF-beta signals. FEBS Lett. 1998 Jul 3;430(3):201-4.

2. Yagi K, Goto D, Hamamoto T, Takenoshita S, Kato M, Miyazono K. Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J Biol Chem. 1999 Jan 8;274(2):703-9.

3. Mamura M, Nakao A, Goto D, Kato M, Saito Y, Iwamoto I. Ligation of the T cell receptor complexresults in phosphorylation of Smad2 in T lymphocytes. Biochem Biophys Res Commun. 2000 Feb 5;268(1):124-7.

4. Goto D, Nakajima H, Mori Y, Kurasawa K, Kitamura N, Iwamoto I. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling. Biochem Biophys Res Commun. 2001 Mar16;281(5):1100-5.

5. Yagi K, Furuhashi M, Aoki H, Goto D, Kuwano H,Sugamura K, Miyazono K, Kato M. c-myc is a downstream target of Smad pathway. J Biol Chem. 2001 Oct 31

6. Yagi K., Furuhashi M., Aoki H., Goto D., Kuwano H., Sugamura K., Miyazono K., and Kato M.: c-myc is a downstream target of the Smad pathway. J. Biol.Chem. 277(1):854-861,2002

7.Tsutsumi A., Ikegami H., Takahashi R., Murata H., Goto D., Matsumoto I., Fujisawa T., and Sumida T.:Mannose binding lectin gene polymorphism in patients with type I diabetes. Human Immunology. 64: 621-624, 2003

8. Kojo S., Tsutsumi A., Goto D., and Sumida T.: Low expression levels of soluble CD1d gene in patients with rheumatoid arthritis. The journal of Rheumatology. 30:2524-2528,2003

9. Murata H., Adachi Y., Ebitsuka T., Chino Y., Takahashi R., Hayashi T., Goto D., Matsumoto I., Tsutsumi A., Akaza H., and Sumida T.:
Reiter's syndrome following intravesical Bacille bilie de Calmette-Guerin treatment for superficial bladder carcinoma. Report of six cases Mod. Rheumatol. 14:82-86,2004

10.Takahashi R., Tsutsumi A., Ohtani K., Goto D., Matsumoto I., Ito S., Wakamiya N., and Sumida T.:
Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus. Clin. Exp. Immunol.136(3):585-590,2004

11.Muraki Y., Tsutsumi A., Takahashi R., Suzuki E., Hayashi T., Chino Y., Goto D., Matsumoto I.,Murata H., Noguchi E., and Sumida T.:
Polymorphisms of IL-1β Gene in Japanese Patients with Sjogren’s Syndrome and Systemic Lupus Erythematosus.
J. Rheumatol.31:720-725,2004

12.Muraki Y., Matsumoto I., Chino Y., Hayashi T., Suzuki E., Goto D., Ito S., Murata H., Tsutsumi A., Sumida T.:
Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies.Possible mechanism of autoantibody production
Biochem. Biophys. Research. Commun.323(2):518-522,2004

13.Takahashi R., Tsutsumi A., Ohtani K., Muraki Y., Goto D., Matsumoto I., Wakamiya N., and Sumida T.:
Association of mannose-binding lection(MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus.
Ann. Rheum. Dis.64(2):311-314,2005

14.Naito Y., Matsumoto I., Wakamatsu E., Goto D., Sugiyama T., Matsumura R., Ito S., Tsutsumi A., Sumida T.:
Muscariinic acetylcholine recepter auto antibodies in patients with Sjogren's syndrome.
Ann. Rheum. Dis.64(3):510-511,2005

15.Tomoo T., Tsutsumi A., Yasukochi T., Ikeda T., Ochiai N., Ozawa K., Shibanaka Y., Ito S., Matsumoto I., Goto D., Sumida T.:
Analysis of abnormally expressed genes in synovium from patients with rheumatoid arthritis using a column gel electrophoresis-coupled subtractive hybridization technique.
Int. J. Mol. Med.15(3):453-457,2005

16.Suzuki T., Muraki Y., Yasukochi T., Hua Zhang., Kori Y., Wakamatsu E., Hayashi T., Goto D., Ito S., Tsutsumi A., Sumichika H., Sumida T., Matsumoto I.:
Immunoglobulin G from anti-glucose-6-phosphate isomerase antibodies positive patient with rheumatoid arthritis induces synovitis in cynomolgus monkeys
Autoimmunity Reviews 4:475-478,2005

17.Hayashi T, Matsumoto I, Muraki Y, Takahashi R, Chino Y, Goto D, Ito S, Tsutsumi A, Sumida T.:
Clinical Characteristics of Anti-Glucose-6-Phosphate Isomerase Antibodies positive Japanese Patients with Rheumatoid Arthritis
Modern Rheumatoloogy 15:258-263,2005

18.Matsumoto I, Muraki Y, Yasukochi T, Hua Zhang, Kori Y, Hayashi T, Goto D, Ito S, Tsutsumi A, Ikeda K, Sumichika H, Sumida T.:
The exploration of joint-specific immunoreactions on immunoglobulins G of anti-glucose-6-phosphate isomerase antibody-positive patients with rheumatoid arthritis
IInt. J. Mol. Med .16(5):793-800,2005

19.Matsumoto I, Hua Zhang, Muraki Y, Hayashi T, Yasukochi T, Kori Y, Goto D, Ito S, Tsutsumi A, Sumida T.:
A functional variant of Fcy receptor IIIA is associated with rheumatoid arthritis in anti-glucose-6-phosphate isomerase antibodies-positive individuals
Arthritis. Res. Ther. 7:1183-1188,2005

20.Miyahara S, Ito S, Soeda A, Chino Y, Hayashi T, Takahashi R, Goto D, Matsumoto I, Tsutsumi A, Sumida T.
Two cases of systemic lupus erythematosus complicated with colonic ulcers.
Intern Med.44(12)1298-1306,2005

21.Kori Y., Matsumoto I., Hua Zhang., Yasukochi T., Hayashi T., Iwanami K., Goto D., Ito S., Tsutsumi A., Sumida T.:
Characterization of Th1/Th2 type, glucose-6-phosphate isomerase reactive T cells in the generation of rheumatoid arthritis
Ann. Rheum. Dis.65:968-969,2006

22.Ito S, Sugihara M, Suzuki T, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Diagnosis of Chlamydia-induced reactive arthritis
Intern Med(letter) 45(1)37-37,2006

23.Ohnishi Y, Tsutsumi A, Goto D, Ito S, Matsumoto I, Taniguchi M,Sumida T.:
TCRVa14+NKT cells function as effector T cells in collagen-induced arthritis mice
Clin. Exp. Immunol. 141:47-53,2005

24.Kitagawa M, Goto D, Mamura M, Matsumoto I, Ito S, Tsutsumi A, Sumida T.:
Inhibitory peptides of CD40/CD154 interaction.
Mod.Rheumatol. 15:423-426,2005

25.Naito Y, Matsumoto I, Wakamatsu E, Goto D, Ito S, Tsutsumi A, Sumida T.:
Altered peptide ligants regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjogren's Syndrome
Ann. Rheum. Dis. 65:269-271,2006

26.Chino Y, Murata H, Goto D, Matsumoto I, Tsutsumi A, Sakamoto T, Ohtsuka M, Sekisawa K, Ito S, Sumida T.:
T cell receptor BV gene repertoire in lymphocytes from bronchoalveolar lavage fjuid of polymyositis/dermatomyositis patients with interstitial pneumonitis.
Int. J. Mol. Med. 17:101-109,2006

27.Suzuki E, Tsutsumi A, Goto D, Matsumoto I, Ito S, Otsu M, Onodera M, Takahashi S, Sato Y, Sumida T.:
Gene transduction of tristetraprolin or its active domain reduces TNF-α production in Jurkat T cells.
Int.I.Mol.Med. 17(5)801-809,2006

28.Suzuki E, Hayashi T, Ito S, Miyazaki K, Yamazaki H, Machino T, Takahashi R, Chino Y, Goto D, Matsumoto I, Tsutsumi A, Sato Y, Sumida T.:
A Case of Pulmonary Hypertension Associated with Systemic Lupus Erythematosus without Anti-ribonucleoprotein Antibodies.
ACTA MEDICA et BIOLOGICIA 53(3)87-93,2005

29.Wakamatsu E, Matsumoto I, Yasukochi T, Naito Y, Goto D, Mamura M, Ito S, Tsutsumi A, Sumida T.:
Overexpression of phosphorylated stat1-α in labial salivary glands of patients with Sjogren's Syndrome
Arthritis Rheum 54(11):3476-3484,2006

30.Tsutsumi A, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Sumida T.:
Significnace of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other phospholipids antibody assays.
Mod.Rheumatol.16:158-164,2006

31.Ohnishi Y, Tsutsumi A, Matsumoto I, Goto D, Ito S, Kuwana M, Uemura Y, Nishimura Y, Sumida T.:
Altered peptide ligands control type ?collagen-reactive T cells from RA patients
Mod.Rheumatol.16:226-228,2006

32.Suzuki E, Tsutsumi A, Sugihara M, Mamura M, Goto D, Matsumoto I, Ito S, Ikeda K, Ochiai N, Sato Y, Sumida T.:
Expression of TNF-α, tristetraprolin, T-cell intracellular antigen-1 and Hu antigen R genes in synobium of patients with rheumatoid arthritis.
Int.J.Mol.Med. 18:273-278,2006

33.Wakamatsu E, Nakamura Y, Matsumoto I, Goto D, Ito S, Tsutsumi A, Sumida T.:
DNA microarray analysis of labial salivary gland of patients with Sjogren's syndrome
Ann. Rheum. Dis. 66:844-845,2007

34.Yamada H, Ishii W, Ito S, Iwanami K, Ogishima H, Suzuki T, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Sarcoid myositis with muscle weakness as a presenting symptom
Mod Rheumatol 17：243-246，2007

35.Matsuyama M, Suzuki T, Tsuboi H, Ito S, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
Inten Med 46, 771-774, 2007

36.Sugihara M, Tsutsumi A, Suzuki E, Wakamatsu E, Suzuki T, Ogishima H, Hayashi T, Chino Y, Ishii W, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T.:
Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.
Arthritis Rheum 56(7):2160-2169,2007

37.Enami T, Suzuki T, Ito S, Yoshimi A, Sugihara M, Mamura M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, and Sumida T.:
Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13
Intern Med 46:1033-1037,2007

38.Hayashi T, Matsumoto I, Yasukochi T, Mamura M, Goto D, Ito S, Tsutsumi A, Sumida T.:
Biased usage of synovial immunoglobulin heavy chain variable region 4 by the anti-glucose-6-phosphate isomerase antibody in patients with rheumatoid arthritis.
Int. J. Mol. Med.20(2):247-253,2007

39.Nakamura Y, Wakamatsu E, Matsumoto I, Tomiita M, Kohno Y, Mori M, Yokota S, Goto D, Ito S, Tsutsumi A, Sumida T.:
High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjogren's syndrome
Ann. Rheum. Dis. 67(1)136-137,2008

40.Matsui H, Tsutsumi A, Sugihara M, Suzuki T, Iwanami K, Kohno M, Goto D, Matsumoto I, Ito S, Sumida T.:
Visfatin(pre-B cell colony-enhancing factor) gene expression in patients with rheumatoid arthritis
Ann. Rheum. Dis. 67(4):571-572,2008

41.Wang Y, Ito S, Chino Y, Iwanami K, Yasukochi T, Goto D, Matsumoto I, Hayashi T, Uchida K, Sumida T.:
Use of Laser Microdissection in the Analysis of Renal-infiltrating T cells in MRL/lpr Mice
Mod Rheumatol 18:385-393,2008

41.Iwanami K, Matsumoto I, Watanabe Y, Mihara M, Ohsugi Y, Mamura M, Goto D, Ito S, Tsutsumi A, Kishimoto T, Sumida T.:
Crucial role of IL-6/IL-17 cytokine axis in the induction of arthritis by glucose-6-phosphate-isomerase.
Arthritis Rheum. 58(3):754-763 ,2008

42.Kohno M, Tsutsumi A, Matsui H,Sugihara M, Suzuki T, Mamura M, Goto D, Matsumoto I, Ito S, Suguro T, Sumida T.:
Interleukin 17 gene expression in patients with rheumatoid arthritis
Mod.Rheumatol 18:15-22,2008

43.Ishii W, Ito S, Kondo Y, Tsuboi H, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Okoshi Y, Hasegawa Y, Kojima H, Sakashita S, Aita K, Noguchi M, Sumida T.:
Intravascular large B-cell lymphoma with acute abdomen as a presenting symptom in a patient with systemic lupus erythematosus
J. Clin. Oncol. 26(9):1553-1555,2008

44.Suzuki T, Tsutsumi A, Suzuki E, Sugihara M, Muraki Y, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Sumida T.:
Tristetraprolin(TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals
Mod. Rheumatol 18:472-479,2008

45.Matusmoto I, Zhang H, Yasukochi T, Iwanami K, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
Therapeutic effects of antibodies to TNF alpha and IL-6 and CTLA-4 Ig in mice with glucose-6-phosphate isomerase-induced arthritis
Arthritis Res Ther10:R66,2008

46.Yoshiga Y, Goto D, Segawa S, Ohnishi Y, Matsumoto I, Ito S, Tsutsumi A, Taniguchi M,Sumida T.:
Invariant NKT cells produce IL-17 through IL-23-dependent and -independentpathways with potential modulation of Th17 response in collagen-induced arthritis.
Int.J.Mol.Med. 22:369-374,2008

47. Ito I, Kawasaki A, Ito S, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Geoffrey Hom, Robert R. Graham, Takasaki Y, Hashimoto H, Ohashi J, Timothy W. Behrens, Sumida T, Tsuchiya N.:
Replication of the Association between C8orf13-BLK Region and Systemic Lupus Erythematosus in a Japanese Population.
Arthritis Rheum. 60(2):553-558,2009

48.Kawasaki A, Ito I, Hikami K, Ohashi J, Hayashi T, Goto D, Matsumoto I, Ito S, Tsutsumi A, Koga M, Arinami T, Robert R Graham, Geoffrey Hom, Takasaki Y, Hashimoto H, Timothy W Behrens, Sumida T, Tsuchiya N.:
Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of STAT1-STAT4 region.
Arthritis Res Ther. 10:R113,2008

49. Tanaka-Watanabe Y, Matsumoto I, Iwanami K, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
B cell play crucial role as antigen presenting cells and collaborationg with inflammatory cytokines in glucose-6-phoaphate isomerase-induced arthritis.
Clin. Exp. Immunol. 155:285-294,2009

50.Iwanami K, Matsumoto I, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
Arthritogenic T cell epitope in glucose-6-phosphate isomerase (GPI)-induced arthritis.
Arthritis Res Ther 10(6):R130. Epub ,2008

51.Tsutsumi A, Kobayashi T, Ito S, Goto D, Matsumoto I, Yoshie H, Sumida T.:
Mannose binding lection gene polymorphisms and the severity of chronic periodontitis.
Jap.J.Clin.Immunol 32:48-52,2009

52.Horikoshi M, Ito S, Ishikawa M, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show reduced or insufficient response to infliximab.
Mod Rheumatol 19:229-234,2009

53.Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A new low-field extremity magnetic resonance imaging and proposed compact MRI score- Evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis.
Mod Rheumatol 19:358-365,2009

54.Wakamatsu E, Matsumoto I, Yoshiga Y, Hayashi T, Goto D, Ito S, Sumida T.:
Altered peptide ligands regulate type II collagen-induced arthritis in mice
Mod Rheumatol 19:366-371,2009

55.Kondo Y, Ito S,Ohi Y, Satou H, Hiraoka T, Tsuboi H, Sugihara M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Atypical Cogan's Syndrome with Aortitis.
Intern. Med 48:1093-1097,2009

56.Inoue A, Matsumoto I, Tanaka Y, Iwanami K, Kanamori A, Ochiai N, Goto D, Ito S, Sumida T.:
Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis.
Arthritis Res Ther.11(4):R118. Epub 2009 Aug 6

56.Segawa S, Goto D, Yoshiga Y, Hayashi T, Matsumoto I, Ito S, Sumida T.:
Low levels of soluble CD1d protein alters NKT cell function in patients with rheumatoid arthritis.
Int. J. Mol. Med.24(4):481-486,2009

57.Wang Y, Ito S, Chino Y, Goto D, Matsumoto I, Murata H, Tsutsumi A, Hayashi T, Uchida K, Usui J, Yamagata K,Sumida T.:
Laser Microdissection-based Analysis of Cytokine Balance in the Kidneys of Patients with Lupus Nephritis
Clin. Exp. Immunol. 159(1):1-10,2010

58. Ito I, Kawasaki A, Ito S, Kondo Y, Sugihara M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Takasaki Y, Hashimoto H, Matsuta K, Sumida T, Tsuchiya N.:
Replication of association between FAM167A(C8orf13)-BLK region and rheumatoid arthritis in a Japanese population.
Ann. Rheum. Dis.(in press)

59.Iwanami K, Matsumoto I, Yoshiga Y, Inoue A, Kondo Y, Yamamoto K, Tanaka Y, Minami R, Hayashi T, Goto D, Ito S, Nishimura Y, Sumida T.:
Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.
Arthritis Res Ther.11:R167,Epub2009 Nov 9

60.Satoh T, Ishikawa O, Ihn H, Endo H, Kawaguchi Y, Sasaki T, Goto D, Takahashi K, Takahashi H, Misaki Y, Mimori T, Muro Y, Yazawa N, Sato S, Takehara K, Kuwana M.:
Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.
Rheumatology 48:1570-1574,2009

61.Umeda N, Ito S, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment.
Intern. Med.49:187-189,2010

62.Segawa S, Goto D, Yoshiga Y, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T.:
Inhibition of transforming growth factor-b signaling attenuates IL-18 plus IL-2-induced interstitial lung disease in mice.
Clin. Exp. Immunol.160:394-402,2010

63.Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Sugihara M, Horikoshi M, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
New low-field extremity MRI, compacTscan: comparison with whole body 1.5 tesla conventional MRI.
Mod. Rheumatol. 20(4):331-336,2010

64. Kawasaki A, Ito I, Ito S, Hayashi T, Goto D, Matsumoto I, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of TNFAIP3 polymorphism with susceptibility to systemic lupus erythematosus in a Japanese population.
Journal of Biomedicine and Biotechnology. Epub 2010 May 27

65.Ogishima H, Ito S, Tsutsumi A, Sugihara M, Goto D, Matsumoto I, Obata-Yasuoka M,  Hamada H, Yoshikawa H, Takahashi H, Murashima A, Sumida T.:
High dose unfractionated heparin therapy in a pregnant patient with antiphospolipid syndrome: a case report
International Journal of Rheumatic Diseases13(3):e32-e35,2010

66.Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, Goto D, Ito S, Sumida T.:
New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren’s syndrome.
Clin. Exp. Immunol. 162:53-61, 2010

67. Hayashi T, Ito S, Goto D, Matsumoto I, Sumida T.:
Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis.
Modern Rheumatology 20:548-555,2010

68.Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T.:
Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren's syndrome-like sialoadenitis.
J.Autoimmunity 35:383-389,2010

69.Tsuboi H, Wakamatsu E, Iizuka M, Nakamura Y, Sugihara M, Suzuki T, Ogishima H, Hayashi T, Goto D, Ito S, Matsumoto I, Sumida T.:
Importance of serine727 phosphorylated STAT1 in IFNgamma-induced signaling and apoptpsis of human salivary gland cells.
Int J Rheum Dis. 14:86-91,2011

70.Kawasaki A, Ito S, Furukawa H, Hayashi T, Goto D, Matsumoto I, Kusaoi M, Ohashi J, Graham R R, Matsuta K, Behrens T W, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population : a case-control association study.
Arthritis Res. Ther.12:R174,2010

71.Akashi N, Matsumoto I, Tanaka Y, Inoue A, Yamamoto K, Tanaka Y, Umeda N, Hayashi T, Goto D, Ito S, Sekiguchi K, Sumida T.:
Comparative suppressive effect in models of autoimmune arthritis by tyrosine kinase inhibitors imatinib and nilotinib.
Mod. Rheumatol 21:267-275,2011

72.Segawa S, Goto D, Yoshiga Y, Horikoshi M, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T.:
Involvement of NK 1.1-Positive {gamma}{delta}T Cells in Interleukin-18 Plus Interleukin-2-Induced Interstitial Lung Disease.
Am. J. Res. Cell. Mol. Biol. 45(3):659-666,2011

73.Yoshiga Y, Goto D, Segawa S, Horikoshi M, Hayashi T, Matsumoto I, Ito S, Taniguchi S, Sumida T.:
Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.
Clin. Exp. Immunol. 164(2):236-247,2011

74.Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Minami R, Umeda N, Kanamori A, Ochiai N, Miyazawa K, Sugihara M, Hayashi T, Goto D, Ito S, Sumida T.:
Six-transmembrane epithelial antigen of prostate4(STEAP4) is TNFalpha-induced protein that regulates IL-6, Il-8, and cell proliferation in synovium from patients with rheumatoid arthritis
Mod. Rheumatol 22:128-136, 2012

75.Yamaguchi T, Ito S, Takano Y, Umeda N, Goto M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A case of a disseminated sporotrichosis patient treated with prednisolone, immunosuppressants, and tocilizumab under the diagnosis of rheumatoid arthritis.
Intern. Med.51(15):2035-9,2012

74.Horikoshi M, Goto D, Segawa S, Yoshiga Y, Iwanami K, Inoue A, Tanaka Y, Matsumoto I, Sumida T.:
Activation of invariant NKT cells with glycolipid ligand α-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis.
PLoS One 7(12):e51215,2012

75.Hasegawa M, Asano Y, Endo H, Fujimoto M, Goto D, Ihn H, Inoue K, Ishikawa O, Kawaguchi Y, Kuwana M, Ogawa F, Takahashi H, Tanaka S, Sato S, Takehara K.:
Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study.
Mod Rheumatol 23(6):1076-84,2013

76.Ito S, Ogishima H, Kondo Y, Sugihara M, Hayashi T, Chino Y, Goto D, Matsumoto I, Sumida T.:
Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases.
Mod Rheumatol 21(1):52-59,2014

77.Segawa S, Goto D, Horikoshi M, Kondo Y, Umeda N, Hagiwara S, Yokosawa M, Hirota T, Miki H, Tsuboi H, Ogishima H, Suzuki T, Matsumoto I, Sumida T.：
Involvement of CD161+Vδ1+γδT cells in systemic sclerosis: Association with interstitial pneumonia.
Rheumatology(Oxford) 53(12):2259-69,2014

78.Segawa S, Goto D, Iizuka A, Kaneko S, Yokosawa M, Kondo Y, Matsumoto I, Sumida T.:
The regulatory role of IFN-g producing gammadelta T cells via the suppression of Th17 cell activity in bleomycin-induced pulmonary fibrosis.
Clin Exp Immunol 185(3):348-60,2016

79.Iizuka A, Segawa S, Kondo Y, Kaneko S, Yokosawa M, Furuyama K, Miki H, Tahara-Hanaoka S, Shibuya A, Tsuboi H, Goto D, Matsumoto I, Shibayama S, Sumida T.:
Allergy inhibitory receptor-1 inhibits autoantibody production via upregulation of apoptotic debris clearance by macrophages.
Int J Rheum Dis 21(12):2071-2078,2018

80.Segawa S, Kondo Y, Nakai Y, Iizuka A, Kaneko S, Yokosawa M, Furuyama K, Tsuboi H, Goto D, Matsumoto I, Sumida T.:
Placenta specific-8 suppresses IL-18 production through regulation of autophagy and is associated with Adult Still’s disease.
J Immunol 201(12):3534-3545,2018

81.Morinaka S, Takano Y, Goto D, Sumida T.:
Familial HLA-B*52 vasculitis: Maternal, atypical Coganﾕs syndrome with Takayasu arteritis-mimicking aortitis and filial Takayasu arteritis.
Intern Med. (in press)